AbstractProspective multicenter phase II study of the anti-EGFR (epidermal growth factor receptor) antibody panitumumab (P) in patients with platinum pre-treated, advanced head and neck squamous cell cancer (HNSCC

First Page		Document Content
Date: 2016-08-08 11:22:57		AbstractProspective multicenter phase II study of the anti-EGFR (epidermal growth factor receptor) antibody panitumumab (P) in patients with platinum pre-treated, advanced head and neck squamous cell cancer (HNSCC Add to Reading List Source URL: www.ctueoc.ch Download Document from Source Website File Size: 968,77 KB Share Document on Facebook